ArticleCancer research and treatment2021

Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.

Lin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.